Clinical Trial

Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine

Name: Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine — clinical trial record (NCT07683949)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LENCAP-CRC

Enrolling by Invitation Phase 1/2

View on ClinicalTrials.gov →

Summary

A New Treatment Opportunity for Patients with Advanced Colorectal Cancer Refractory to Standard Chemotherapy: Clinical Trial of Capecitabine plus Lenvatinib Combination Therapy

Trial Details

NCT Number	NCT07683949
Lead Sponsor	Seoul National University Bundang Hospital Collaborators: Seoul National University Hospital
Conditions	Advanced Colorectal Cancer (Part 1)
Enrollment	93 participants
Start Date	2026-06-15
Primary Completion	2029-10-31 (estimated)
Study Completion	2029-10-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-06